Navigation Links
NOVAVAX Reports Fourth Quarter and 2010 Year-End Financial Results
Date:3/28/2011

ification from U.S. Department of Health and Human Services Biomedical Advanced Research and Development Authority (HHS BARDA) that the Company's proposal to provide recombinant influenza vaccine products and manufacturing capabilities for pandemic preparedness was in the competitive range for award of an advanced development contract ($179 million contract award was announced subsequently in February 2011)
  • Reported positive clinical results from first-stage of 2009 H1N1 vaccine trial in Mexico (final results were presented in February 2011 at World Health Organization conference in Geneva)
  • Reported positive clinical results from Phase II seasonal influenza vaccine study in older adults
  • Completed construction and initiated validation testing of state-of-the-art vaccine production facility in India under the Company's joint venture with Cadila Pharmaceuticals
  • Received FDA clearance and initiated launch of a Phase I clinical trial in respiratory syncytial virus (RSV)
  • Published safety and efficacy findings from multiple pre-clinical studies supporting development of RSV vaccine based on virus-like particles
  • Received a key U.S. patent covering technology for rapid, efficient and uniform production of VLP-based vaccines against current and future strains of seasonal and pandemic influenza
  • Elected Stanley C. Erck as Executive Chairman of the Board of Directors and Richard H. Douglas, Ph.D. and James F. Young, Ph.D. as new Board of Director members
  • Awarded nearly $1 million in grants under the Internal Revenue Service's Therapeutic Discovery Project to support the development of VLP-based vaccines
  • Announced promotions of manufacturing managers and appointment of new Chief Medical Officer

  • Anticipated events in 2011:

  • Launch Phase II trial of seasonal influenza vaccine (under HHS BARDA contract)
  • Report top-line clinical data from Phase I RSV trial
  • Develop manuf
    '/>"/>

  • SOURCE Novavax, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. Novavax CEO to Present at ACUMENBioFins 9th Annual Healthcare Conference
    2. Novavax Reports Third Quarter 2007 Financial Results and Progress with Vaccine Development Programs
    3. GE Healthcare and Novavax Establish Collaboration To Develop and Market Pandemic Influenza Solution
    4. Novavax Announces Preclinical Results for Seasonal Influenza Vaccine Program
    5. Novavax Announces Favorable Interim Results from Human Clinical Trial for Its Pandemic Influenza Vaccine Program
    6. Novavax Reports Fourth Quarter and 2007 Year-End Financial Results
    7. Novavax Reports Positive Results from Preclinical Studies of its VLP-based Trivalent Seasonal Influenza Vaccine Candidate
    8. Novavax Completes Enrollment in Phase I/IIa Pandemic Influenza Vaccine Clinical Trial
    9. Novavax Announces Proprietary Method to Create SARS Vaccine and Renewal of NIH Funding for SARS Vaccine Development
    10. Novavax to Present Phase I/IIa Trial Data Results in an Investor Conference Call on August 26, 2008
    11. Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/3/2015)... and REHOVOT, Israel, Sept. 3, 2015 ... and developing innovative therapies for ear, nose, and throat ... Company,s Newport Gateway office complex to be the location ... the move by end of September and will have ... U.S. Headquarters: OticPharma, Inc. 19900 MacArthur Blvd., ...
    (Date:9/2/2015)...  The report on breast cancer therapeutics: pipeline analysis ... on the basis of the molecules which are currently ... lining of milk ducts or lobules responsible for supplying ... that can spread to other cells present in the ... is referred as lobular carcinoma, while the other that ...
    (Date:9/2/2015)... , Sept. 2, 2015 Advanced Wound ... Summary Advanced dressings have steadily replaced traditional ... a variety of wound indications, such as trauma ... infection control, and physical protection become increasingly critical ... role in standard therapy. This report focuses ...
    Breaking Medicine Technology:OticPharma Establishes U.S. Headquarters in Orange County, California 2Breast Cancer Therapeutics: Pipeline Analysis Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023 2Breast Cancer Therapeutics: Pipeline Analysis Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023 3Advanced Wound Dressings - 5EU Analysis and Market Forecasts 2
    ... and STOCKHOLM , April 23 ... radiosurgical instrument that bears his name and a faculty ... performed the world,s first Gamma Knife ® surgery ... Leksell Gamma Knife. Karolinska University Hospital recently acquired Elekta,s ...
    ... VIENNA , April 23, 2010 AFFiRiS AG,s ... clinical testing.,It may therefore be possible to confirm the efficacy ... of this efficacy study comes only five,months after the completion ... several disease areas and is currently developing a total of,twelve ...
    Cached Medicine Technology:Karolinska University Hospital Acquires Leksell Gamma Knife Perfexion to Expand Radiosurgery Versatility, Efficiency in Brain Cancer Therapy 2Karolinska University Hospital Acquires Leksell Gamma Knife Perfexion to Expand Radiosurgery Versatility, Efficiency in Brain Cancer Therapy 3AFFiRiS AG: Alzheimer's Vaccine AD02 Already in Clinical Phase II 2AFFiRiS AG: Alzheimer's Vaccine AD02 Already in Clinical Phase II 3AFFiRiS AG: Alzheimer's Vaccine AD02 Already in Clinical Phase II 4
    (Date:9/3/2015)... ... September 03, 2015 , ... Representatives with ... at the highly anticipated Mississippi Gulf Babypalooza on September 19, 2015. , “We ... from Gulfport, Biloxi, and beyond. We will be discussing setting up college funds, ...
    (Date:9/3/2015)... ... September 03, 2015 , ... At Renew Man™, we have seen an ... health care model, where the primary care physician dictates and the patient obeys. Instead, ... educated about their health issues and empowered to choose their own treatment options. , ...
    (Date:9/3/2015)... ... September 03, 2015 , ... About 220,800 new cases of prostate cancer are reported each year, ... diagnosed with prostate cancer during their lifetime. While only one man in 10,000 will typically ... by age 65, according to the American Cancer Society. , Prostate ...
    (Date:9/3/2015)... ... September 03, 2015 , ... James Earl Jones will ... wellness. In this episode, James Earl Jones will introduce a segment that discusses why ... workplace and how workplace wellness can be fostered in any working environment. , Employers ...
    (Date:9/3/2015)... FLORIDA (PRWEB) , ... September 03, 2015 , ... ... of the highest-regarded health professionals out there. His perspective on internal medicine keeps patients ... stay happy and healthy is important regardless of the season, but even more so ...
    Breaking Medicine News(10 mins):Health News:State Farm Agent EJ Roberts to Help Expecting Mothers at the Mississippi Gulf Babypalooza 2Health News:Men Dissatisfied with the Primary Care Physician’s Approach to Andropause Are Turning to Renew Man™ 2Health News:Men Dissatisfied with the Primary Care Physician’s Approach to Andropause Are Turning to Renew Man™ 3Health News:Noted Santa Rosa Urologist Dr. Michael Lazar Provides Insights on Prostate Cancer Treatments in Recognition of Prostate Cancer Awareness Month 2Health News:Noted Santa Rosa Urologist Dr. Michael Lazar Provides Insights on Prostate Cancer Treatments in Recognition of Prostate Cancer Awareness Month 3Health News:James Earl Jones Hosts a New "Voices In America" Piece on Making the Workplace Healthier 2Health News:Doctor Kayode Sotonwa Highlights Expert Tips for Staying in Shape This Fall 2
    ... Eli Lilly and Company (NYSE: LLY ) today declared a ... outstanding common stock. This is the same dividend as was paid ... rate for 2009 of $1.96 per share. , , The ... close of business on August 15, 2009. , , About Lilly ...
    ... blames physician misdiagnosis as the likely cause of apparent uptick ... A newly released study in the June 2009 British Journal ... the eastern United Kingdom has concluded that the much-hyped melanoma ... The study attributed the increase in melanoma diagnoses to heightened ...
    ... Now there,s a new reason for the,weight-conscious to drink fat ... the July issue of the American Journal of Clinical,Nutrition. Researchers ... helped increase satiety, or a feeling of fullness, and lead ... a fruit drink. The,milk drinkers ate about 50 fewer calories ...
    ... Personalized Medicine Meeting Elicits Varying Perspectives , , WASHINGTON, ... to regulate genetic testing is problematic, according to a recent ... of the attendees at a colloquium on personalized medicine, sponsored ... American Association for the Advancement of Science (AAAS) responded "yes" ...
    ... to attend field hearing exploring use of Recovery Act funds ... Senator Benjamin L. Cardin (D-MD ), chaired a field hearing ... Entrepreneurship in Rockville, MD, entitled " Missed Opportunities: The ... local and national experts in biotechnology testified about the important ...
    ... Center,s two camps, Camp Courage in Maple Lake and Courage North ... people with disabilities. , , A recent Muscular Dystrophy camp ... MDA staff) who tested positive for H1N1 flu (also known as ... officials were contacted by the MDA locally three days after the ...
    Cached Medicine News:Health News:New Study Says Purported Melanoma Epidemic is Vastly Overstated 2Health News:Drinking Milk in the Morning May Help Stave off Lunchtime Hunger 2Health News:FDA's Current Ability to Regulate Genetic Testing is Problematic, FDLI-AAAS Colloquium Attendees Say 2Health News:FDA's Current Ability to Regulate Genetic Testing is Problematic, FDLI-AAAS Colloquium Attendees Say 3Health News:Cardin Calls on NIH to Utilize Small Businesses for Extramural Research Projects 2Health News:Courage Camps Maintain Summer Camp Schedule for Children and Adults With Disabilities 2
    ... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
    ... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    ... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
    Medicine Products: